Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Yesway, Inc. (YSWY)
NASDAQConsumer StaplesGrocery StoresSnapshot 2026-11-05
$25.09-0.44%
Close 2026-11-05 · 1-day change
NASDAQConsumer StaplesGrocery StoresSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
1.20 → 1.20 EPS · FY ending Dec 31, 2027 · 5 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for YSWY yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Effective management of capital allocation must be maintained | A supporting condition in Yesway, Inc.'s published investment case. The stated target is Maintain shareholder value through strategic equity management. | Intact | failure to execute on capital allocation strategy | Qualitative condition This condition has no defined numerical measure. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a consumer staples business with a sector tailwind, but the evidence does not establish it as a durable compounder or a turnaround. Management is stable, while the long-term thesis remains insufficiently clear because recent financial history is limited and execution results are mixed.
The valuation evidence is too thin to judge whether YSWY is cheap, fair, or expensive versus peers, and the model’s confidence does not provide a valuation conclusion. The snapshot reports low fragility, but it does not show what earnings expectations the market already assumes.
Near-term, repeated earnings misses make the next report a meaningful watch point. Over the multi-year view, operating income rose from $36.7 million in 2025-Q2 to $47.7 million in 2026-Q2, while net income fell from $24.2 million to $16.3 million, so profitability progress is mixed. The April 2026 M&A agreement has not yet shown a measurable revenue or earnings contribution.
The multi-year thesis depends on whether higher operating income becomes more consistent net income and whether the announced M&A activity delivers measurable results. Near-term, a weakening jobs trend could add pressure, while continued earnings strength from sector peers could support the sector backdrop; misses or lower guidance from those peers could weaken that tailwind.
For the next 1 to 3 years, YSWY has some evidence of operating improvement and a supportive sector backdrop, but repeated earnings misses and unproven M&A keep the thesis uncertain. The evidence is too limited for a firm conclusion. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Newly stated in 2026-Q2 with filings in April 2026 describing equity sales and shareholder rights modifications. No direct financial metrics provided to measure impact yet. Trajectory is newly stated with limited progress visible in financials.
Pursue M&A activity to support growth | A supporting condition in Yesway, Inc.'s published investment case. The stated target is Engage in at least one significant acquisition. | Intact | failure to announce any M&A activity | M&A activity confirmed vs target of >=1 by FY26 M&A activity event recorded on 2026-04-27; no evidence of stalled recovery or failure to announce M&A. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextNewly stated in 2026-Q2 with a material definitive agreement filed in April 2026 indicating M&A activity. No financial results or revenue impact disclosed yet. Trajectory is newly stated with no measurable delivery so far. Delivery assessment Oct 31, 2026 |
Operating income must continue to improve | Yesway is improving its profitability and operating income. | Under Pressure | operating income falls below $45M | Operating income: $47.744M FY2026-Q2; GAAP. Published target: >=$50M. Target period is not explicitly aligned with this observation. Aug 13, 202647,744,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 quarters: 2025-Q2 and 2026-Q2. Operating income increased from $36.7M in 2025-Q2 to $47.7M in 2026-Q2, indicating progress in profitability. Net income was $24.2M in 2025-Q2 but declined to $16.3M in 2026-Q2, showing mixed results. Overall, the trajectory shows delivering improvement in operating income but net income is less consistent. Delivery assessment Oct 31, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.16 → $1.20 · observed estimates
$3.22B → $3.24B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-27 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-08-28 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-08-29 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-08-30 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-08-31 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-01 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-02 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-03 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-04 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-05 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-06 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-07 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-08 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-09 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-10 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-11 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-12 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-13 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-14 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-15 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-16 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-17 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-18 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-19 | $1.16 | $3,221,137,525 | 5 / 6 |
| 2026-09-20 | $1.16 | $3,219,337,525 | 5 / 6 |
| 2026-09-21 | $1.16 | $3,219,337,525 | 5 / 6 |
| 2026-09-22 | $1.16 | $3,219,337,525 | 5 / 6 |
| 2026-09-23 | $1.20 | $3,230,282,834 | 5 / 6 |
| 2026-09-24 | $1.20 | $3,230,282,834 | 5 / 6 |
| 2026-09-25 | $1.20 | $3,230,282,834 | 5 / 7 |
| 2026-09-26 | $1.20 | $3,230,282,834 | 5 / 7 |
| 2026-09-27 | $1.20 | $3,230,282,834 | 5 / 7 |
| 2026-09-28 | $1.20 | $3,230,282,834 | 5 / 7 |
| 2026-09-29 | $1.20 | $3,230,282,834 | 5 / 7 |
| 2026-09-30 | $1.20 | $3,230,282,834 | 5 / 7 |
| 2026-10-01 | $1.20 | $3,230,282,834 | 5 / 7 |
| 2026-10-02 | $1.20 | $3,230,280,872 | 5 / 7 |
| 2026-10-03 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-04 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-05 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-06 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-07 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-08 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-09 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-10 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-11 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-12 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-13 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-14 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-15 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-16 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-17 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-18 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-19 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-20 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-21 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-22 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-23 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-24 | $1.20 | $3,233,493,372 | 5 / 7 |
| 2026-10-25 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-10-26 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-10-27 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-10-28 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-10-29 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-10-30 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-10-31 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-11-01 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-11-02 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-11-03 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-11-04 | $1.20 | $3,241,755,872 | 5 / 7 |
| 2026-11-05 | $1.20 | $3,241,755,872 | 5 / 7 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.